ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment)
NCT01475045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1160
Last updated 2011-11-21
Summary
The aim of the study is to compare patients' satisfaction from the use of three different inhalation devices by using the FSI-10 questionnaire
Conditions
Sponsors & Collaborators
-
Elpen Pharmaceutical Co. Inc.
lead INDUSTRY
Principal Investigators
-
Asimina Gaga · 7th Pulmonary Clinic, Sotiria Hospital of Athens
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-04-30
- Completion
- 2011-09-30
Countries
- Greece
Study Locations
More Related Trials
-
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01053988 ·Status: COMPLETED ·Phase: PHASE3
-
Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects
NCT02586493 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease
NCT06434792 ·Status: RECRUITING ·Phase: PHASE2
-
Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.
NCT00783406 ·Status: COMPLETED ·Phase: PHASE2
-
Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis
NCT02782312 ·Status: COMPLETED ·Phase: PHASE4
-
A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)
NCT01978145 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)
NCT05114434 ·Status: UNKNOWN
-
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease
NCT00774761 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancement of in-Vitro GC Function in Patients With COPD
NCT00241631 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
NCT07116889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients
NCT01344655 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01017952 ·Status: COMPLETED ·Phase: PHASE3
-
A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.
NCT00468975 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
NCT04542057 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
NCT00358436 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
NCT04535986 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease
NCT04091360 ·Status: COMPLETED ·Phase: PHASE2
-
Three Treatment of Chronic Obstructive Pulmonary Disease Patients
NCT04520230 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
NCT00808288 ·Status: COMPLETED ·Phase: PHASE2
-
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
NCT02552160 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Ensifentrine for 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT05743075 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT01966549 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
NCT00559312 ·Status: COMPLETED ·Phase: NA
-
Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
NCT03480997 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
NCT07016412 ·Status: RECRUITING ·Phase: PHASE2